NCT02881437View on ClinicalTrials.gov

IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 11, 2016

Primary Completion Date

March 16, 2018

Study Completion Date

November 30, 2018

Conditions
Primary Immunodeficiency
Interventions
DRUG

IgHy10

Sub Cutaneous IgHy10 administration

Trial Locations (7)

13005

Hôpital de la Conception, Marseille

33604

Hôpital Haut Lévèque, Pessac

44093

CHU de Nantes - Hôtel Dieu, Nantes

67000

CHU de Strasbourg, Strasbourg

75010

Hôpital St Louis, Paris

75015

Hôpital Necker, Paris

Unknown

CHRU, Hôpital Claude Huriez, Lille

Sponsors

Collaborators (1)

Shire
All Listed Sponsors
collaborator

Shire

INDUSTRY

lead

University Hospital, Lille

OTHER